ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK
  • 0.0 (0)
  • LIFE SCIENCES

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

  1. Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    5D AGO

    Advancements in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies.  Join us as we summarize key takeaways from these thought-provoking presentations:  Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo  Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia  C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu  This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    22 min
  2. ATTD AI School for Clinicians, ATTD 2026 Conference Catch-Up

    5D AGO

    ATTD AI School for Clinicians, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use.  Join us as we summarize key takeaways from these thought-provoking presentations:  Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz  Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey  Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri  Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca  This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    19 min
  3. Continuous Glucose Monitoring Outside the Traditional Areas, ATTD 2026 Conference Catch-Up

    5D AGO

    Continuous Glucose Monitoring Outside the Traditional Areas, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management.  Join us as we summarize key takeaways from these thought-provoking presentations:  CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess  CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews  Non-invasive Glucose Monitoring – Dr. Lutz Heinemann  CGM Use in Clinical Trials – Prof. Pratik Choudhary  This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    24 min
  4. Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    5D AGO

    Cardiovascular Disease in Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes.  While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population.  Join us as we summarize key takeaways from these thought-provoking presentations:  • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel  • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell  • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard  • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch  This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    24 min
  5. Refining Care of Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    5D AGO

    Refining Care of Type 1 Diabetes, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes.  Join us as we summarize key takeaways from these thought-provoking presentations:  Refining Care of Type 1 Diabetes – Dr. Lori Laffel  Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly  Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs  Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck  This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

    17 min
  6. Managing Overweight & Obesity in T1D, ATTD 2026 Conference Catch-Up

    5D AGO

    Managing Overweight & Obesity in T1D, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes.  As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes.  Join us as we summarize key takeaways from these thought-provoking presentations:  • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman  • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown  • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally  This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    18 min
  7. Adjunct Therapies with Automated Insulin Delivery, ATTD 2026 Conference Catch-Up

    5D AGO

    Adjunct Therapies with Automated Insulin Delivery, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes.  As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes.  Join us as we summarize key takeaways from these thought-provoking presentations:  • ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery.  • ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon  • Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar • Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel  This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona.  https://attd.kenes.com

    22 min
  8. ATTD Yearbook Session, ATTD 2026 Conference Catch-Up

    6D AGO

    ATTD Yearbook Session, ATTD 2026 Conference Catch-Up

    In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year.  Join us as we summarize key takeaways from these thought-provoking presentations:  • Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America) • Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America) • New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany) • Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management.  • Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care.  • Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy.  • Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care.  • Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology.  • Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings.  • Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults.  • The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation.  • Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care.  • Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing.  • Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression.  • Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management.  • Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes.  • Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models.  • New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment.  This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026.  Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com

    21 min
See All (65)

Trailers

About

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company) and CGM in Focus (supported by Dexcom). Whether you're a specialist, researcher, or industry leader, hit subscribe.

Information

You Might Also Like